Histamine
Histamine is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Histamine 1522, Positive Skin Test Control - Histamine. Available dosage forms: liquid, injection.
Drug details
- Generic Name
- Histamine
- Brand Names
- Histamine 1522, Positive Skin Test Control - Histamine
- Application Number
- BLA103891
- Sponsor
- Professional Complementary Health Formulas
- NDC Codes
- 2
- Dosage Forms
- LIQUID, INJECTION
- Routes
- ORAL, PERCUTANEOUS
- Active Ingredients
- HISTAMINE DIHYDROCHLORIDE, HISTAMINE
Indications and Usage
INDICATIONS AND USAGE Positive Skin Test Control - Histamine is indicated as an adjunct in allergy skin test for diagnosis, as a positive control to test wheal-flare response of skin for evaluation of skin test response to allergenic extracts.
Warnings
WARNINGS Attacks of severe asthma or other serious allergic conditions may be precipitated by the administration of Histamine Dihydrochloride in patients with bronchial disease. Caution is advised in using histamine in such patients and in those with a history of bronchial asthma. Histamine Dihydrochloride has not been approved for unlabeled use as gastric acid stimulus or for detecting bronchial hyperactivity.